As of June 30, 2026, Star Sports Medicine Co., Ltd Class H carries a market capitalization of 8.50B, placing it among publicly traded companies globally. Its enterprise value stands at 7.24B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 8.50B |
| Enterprise Value | 7.24B |
As of June 30, 2026, Star Sports Medicine Co., Ltd Class H has 54.83M shares outstanding.
| Shares Outstanding | 54.83M |
These figures are as of June 30, 2026.
| PB Ratio | 5.65 |
| P/TBV Ratio | 5.65 |
As of June 30, 2026, Star Sports Medicine Co., Ltd Class H maintains a current ratio of 12.30, meaning it holds 12.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 12.30 |
| Quick Ratio | 10.76 |
| Debt / Equity | 2.39 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 384.00 |
Over the twelve months ended June 30, 2026, Star Sports Medicine Co., Ltd Class H recorded 5.68M in income tax expense.
| Income Tax | 5.68M |
These figures are as of the close on October 22, 2026.
| 50-Day Moving Average | 109.85 |
As of June 30, 2026, Star Sports Medicine Co., Ltd Class H holds 1.30B in cash and equivalents against 36.00M in total debt, resulting in a net debt position of -923.95M. Total book value stands at 1.50B, with working capital of 1.36B providing operational flexibility.
| Cash & Cash Equivalents | 1.30B |
| Total Debt | 36.00M |
| Net Debt | -923.95M |
| Equity (Book Value) | 1.50B |
| Book Value Per Share | 27.45 |
| Working Capital | 1.36B |
These figures cover the twelve months ended June 30, 2026.
| Capital Expenditures | -7.67M |
Already premium?